MedTrace Logo

Symptom Management Essentials at Home

NCT06434545 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2024-05-30

No results posted yet for this study

Summary

A cluster Randomized Controlled Trial (cRCT) that aims to determine the effect of the Palliative Reasoning (PR) methodology on the quality of life and symptom burden of patients dealing with a life-limiting illness and their loved ones, receiving palliative care services at home. Palliative Reasoning will be implemented from the first of may 2024 to 30 april 2025 in twenty nursing teams of a large homecare organization in Utrecht, the Netherlands, and will be compared with twenty control nursing teams. The effect of PR will be measured by means of questionnaires filled out by clients with a life expectancy of less than one year according to the surprise question "Would I be surprised if this person would die within one year?" and family caregivers. Parallel to the effect study, a process evaluation will be conducted in order to understand the implications of the results and its' societal and practical impact.

Conditions

  • Symptom Management

Interventions

BEHAVIORAL

Palliative Reasoning methodology

Twenty nursing teams will be trained in the Palliative Reasoning methodology during a four hour training, split into two sessions. Additionally, teams receive a coaching session ones a month and practice with a real life case every week or two weeks during a one hour team meeting. This will be compared with 20 other nursing teams that will continue to provide care as usual.

Sponsors & Collaborators

  • Zorgbelang Inclusief

    collaborator UNKNOWN

  • Comprehensive Cancer Centre The Netherlands

    collaborator OTHER

  • ROC Midden Nederland

    collaborator UNKNOWN

  • University of Applied Sciences Utrecht

    collaborator OTHER

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Saskia Teunissen, Prof. dr. · UMC Utrecht

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2026-03-31
Completion
2026-07-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06434545 on ClinicalTrials.gov